Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

New Zealand (NZX) Healthcare Sector Analysis

UpdatedFeb 27, 2026
DataAggregated Company Financials
Companies13
  • 7D4.9%
  • 3M0.9%
  • 1Y0.5%
  • YTD0.8%

The Healthcare industry is up 4.9% in the last week, with Fisher & Paykel Healthcare up 9.0%. In the same time, EBOS Group was down 5.6%. Despite this gain, the industry's performance has been flat over the past year. As for the next few years, earnings are expected to grow by 20% per annum.

Sector Valuation and Performance

Has the New Zealand Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 27 Feb 2026NZ$35.0bNZ$19.6bNZ$557.5m18.1x62.8x1.8x
Sun, 25 Jan 2026NZ$35.4bNZ$18.3bNZ$534.5m19.9x66.3x1.9x
Tue, 23 Dec 2025NZ$35.4bNZ$18.2bNZ$532.0m21.2x66.6x1.9x
Thu, 20 Nov 2025NZ$34.6bNZ$18.0bNZ$573.0m22.9x60.4x1.9x
Sat, 18 Oct 2025NZ$33.6bNZ$17.7bNZ$573.4m19.8x58.6x1.9x
Mon, 15 Sep 2025NZ$34.6bNZ$17.6bNZ$570.5m17.8x60.6x2x
Wed, 13 Aug 2025NZ$35.8bNZ$17.6bNZ$571.9m18.6x62.7x2x
Fri, 11 Jul 2025NZ$35.8bNZ$17.6bNZ$570.5m17.9x62.8x2x
Sun, 08 Jun 2025NZ$35.0bNZ$17.4bNZ$568.0m14.8x61.6x2x
Tue, 06 May 2025NZ$34.5bNZ$17.3bNZ$655.4m15.8x52.6x2x
Thu, 03 Apr 2025NZ$34.4bNZ$17.5bNZ$658.9m17x52.2x2x
Sat, 01 Mar 2025NZ$33.7bNZ$17.6bNZ$706.9m16.6x47.7x1.9x
Mon, 27 Jan 2025NZ$36.8bNZ$18.2bNZ$734.3m14.7x50.2x2x
Wed, 25 Dec 2024NZ$36.9bNZ$18.2bNZ$728.5m12.4x50.7x2x
Fri, 22 Nov 2024NZ$37.7bNZ$18.3bNZ$943.4m18.1x40x2.1x
Sun, 20 Oct 2024NZ$37.4bNZ$18.3bNZ$967.8m20.1x38.7x2.1x
Tue, 17 Sep 2024NZ$37.9bNZ$18.1bNZ$963.6m19.9x39.3x2.1x
Thu, 15 Aug 2024NZ$34.6bNZ$17.6bNZ$975.3m20.3x35.5x2x
Sat, 13 Jul 2024NZ$31.5bNZ$17.7bNZ$977.2m16.8x32.2x1.8x
Mon, 10 Jun 2024NZ$30.5bNZ$17.3bNZ$960.3m17.2x31.8x1.8x
Wed, 08 May 2024NZ$30.6bNZ$17.4bNZ$1.3b24.1x23.7x1.8x
Fri, 05 Apr 2024NZ$29.2bNZ$17.4bNZ$1.3b23.8x22.7x1.7x
Sun, 03 Mar 2024NZ$28.9bNZ$17.0bNZ$1.3b18.5x22.4x1.7x
Tue, 30 Jan 2024NZ$29.4bNZ$16.7bNZ$1.1b20.5x26x1.8x
Thu, 28 Dec 2023NZ$28.7bNZ$16.7bNZ$1.1b23.4x25.4x1.7x
Sat, 25 Nov 2023NZ$27.5bNZ$16.6bNZ$1.1b23.1x24.4x1.7x
Mon, 23 Oct 2023NZ$26.8bNZ$16.5bNZ$1.1b31x24.2x1.6x
Wed, 20 Sep 2023NZ$28.3bNZ$16.5bNZ$1.1b28.7x25.6x1.7x
Fri, 18 Aug 2023NZ$29.0bNZ$15.8bNZ$1.1b29.2x27x1.8x
Sun, 16 Jul 2023NZ$30.9bNZ$15.7bNZ$1.1b30.1x28.8x2x
Tue, 13 Jun 2023NZ$29.0bNZ$16.0bNZ$1.1b29.7x26.9x1.8x
Thu, 11 May 2023NZ$31.9bNZ$15.4bNZ$1.6b18.8x20.2x2.1x
Sat, 08 Apr 2023NZ$32.2bNZ$15.4bNZ$1.6b19.4x20.4x2.1x
Mon, 06 Mar 2023NZ$31.2bNZ$15.7bNZ$1.6b18.6x19.7x2x
Price to Earnings Ratio

19.7x


Total Market Cap: NZ$31.2bTotal Earnings: NZ$1.6bTotal Revenue: NZ$15.7bTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Healthcare Sector Price to Earnings3Y Average 40.1x202420252026
Current Industry PE
  • Investors are optimistic on the New Zealander Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 62.8x which is higher than its 3-year average PE of 40.1x.
  • The industry is trading close to its 3-year average PS ratio of 1.9x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 29% per year over the last three years.
  • Meanwhile revenues for these companies have grown 7.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the New Zealand Healthcare sector?

NZ Market1.05%
Healthcare4.89%
Medical Equipment9.03%
Healthcare Services-2.47%
Pharma-5.08%
Biotech-11.11%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 31.4x.
    • Analysts are expecting annual earnings growth of 33.6%, which is higher than its past year's earnings decline of 6.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 45% over the next 5 years.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 14% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
FPH Fisher & Paykel HealthcareNZ$40.909.6%
+NZ$2.1b		20.0%PE55x
SUM Summerset Group HoldingsNZ$10.661.5%
+NZ$38.8m		-13.6%PE7.1x
RYM Ryman HealthcareNZ$2.490.4%
+NZ$10.1m		-19.2%PS3.1x
OCA Oceania HealthcareNZ$0.830.6%
+NZ$3.6m		23.9%PE11.5x
RAD Radius Residential CareNZ$0.391.3%
+NZ$1.4m		87.8%PE9.6x

Latest News

SUM
NZ$10.66
Summerset Group Holdings
7D
1.5%
1Y
-13.6%
EBO
NZ$23.96
EBOS Group
7D
-1.8%
1Y
-39.3%
FPH
NZ$40.90
Fisher & Paykel Healthcare
7D
9.6%
1Y
20.0%

FPH: Improved Guidance And Rating Upgrade Will Support Fairly Valued Outlook

Analysts have lifted their NZ$ fair value estimate for Fisher & Paykel Healthcare from NZ$39.15 to NZ$40.81, citing improved company guidance and a recent upgrade in Street price targets as key supports for the higher range of outcomes. Analyst Commentary Bullish Takeaways Bullish analysts see the higher company guidance as a key support for the uplift in fair value to NZ$40.81, suggesting more confidence in the near term earnings outlook than previously reflected in models.
OCA
NZ$0.83
Oceania Healthcare
7D
0.6%
1Y
23.9%

OCA: Fair Value Will Rely On Slightly Higher Future Profitability

Analysts now set their NZ$0.84 price target for Oceania Healthcare based on slightly updated assumptions for the discount rate, revenue growth, profit margin and future P/E, which fine tune rather than overhaul their previous view. Valuation Changes Fair Value: The NZ$0.84 fair value estimate is unchanged, indicating that the updated inputs leave the overall valuation level intact.
RYM
NZ$2.49
Ryman Healthcare
7D
0.4%
1Y
-19.2%

RYM: Higher Margin Outlook Will Support Updated Sales Guidance

Analysts have lifted their NZ$ fair value estimate for Ryman Healthcare from NZ$3.50 to NZ$3.70, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E multiples. What's in the News Ryman Healthcare reaffirmed its fiscal 2026 sales guidance for occupation right agreements at 1,300 to 1,400, with guidance excluding expected relocations of fewer than 40 residents from Margaret Stoddart and Woodcote care centre closures, which will still appear in reported third quarter 2025 sales volumes (Key Developments).
TAH
NZ$4.91
Third Age Health Services
7D
-7.7%
1Y
56.4%
PEB
NZ$0.20
Pacific Edge
7D
-8.9%
1Y
50.7%
AFT
NZ$3.52
AFT Pharmaceuticals
7D
-3.6%
1Y
30.4%
RAD
NZ$0.39
Radius Residential Care
7D
1.3%
1Y
87.8%
TRU
NZ$0.018
TruScreen Group
7D
-10.0%
1Y
-45.5%
BLT
NZ$0.017
BLIS Technologies
7D
-5.6%
1Y
6.3%

There's Reason For Concern Over BLIS Technologies Limited's (NZSE:BLT) Price

Dec 03
There's Reason For Concern Over BLIS Technologies Limited's (NZSE:BLT) Price
PHL
NZ$0.47
Promisia Healthcare
7D
-1.1%
1Y
25.7%